Prevention tools, MACS at MATRC, and more

MONTHLY | May 2021

MACS provides support to Maryland prescribers and their practices in addressing the needs of their patients with substance use disorders and chronic pain management.

EDUCATION

Upcoming free, virtual CME events

A special Children's Mental Health Matters Week event

Youth and Cannabis in an Era of Increased Access: What’s all the fuss?

Tuesday, May 4, 2021 | 12:30 - 1:30 pm

Presented by Marc Fishman, MD

Maryland’s PDMP: A Tool to Support Safer Prescribing Practices

Thursday, May 6, 2021 | 12 - 1 pm

Presented by Yngvild Olsen, MD

Q&A with Anna Gribble, MSW, MPH

Providers Clinical Support System

Half & Half Waiver Training

Buprenorphine for the Treatment of OUD

Tuesday, May 18, 2021 | 8:30 am - 12:45 pm

Presented by Sarah Kattakuzhy, MD

Fight Stigma: Using the Right Words to Support Patients with Opioid Use Disorder

Monday, May 24, 2021 | 12 - 1 pm

Presented by Bethany DiPaula, PharmD

POLL

Which of the following webinar topics would you most like to see?

Stimulants

Select

Alcohol use disorder

Select

Medications for opioid use disorder & telemedicine

Select

Opioid use disorder care in post-acute & long-term setting

Select

NEWS

MACS TeleECHO Pilot poster presented at MATRC Summit

MACS team members shared the results of the first TeleECHO Clinic cohort at the MATRC Summit in April. This collaborative model of medical education aims to improve access to specialty care through online learning sessions, TeleECHO Clinics. Read more...

Younger age of first cannabis use or prescription drug misuse is associated with faster development of substance use disorders

"A new study shows that in the time after first trying cannabis or first misusing prescription drugs, the percentages of young people who develop the corresponding substance use disorder are higher among adolescents than young adults." Read more...

Putting it into practice: Register for our upcoming webinar on youth and cannabis disorder.

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic

This study suggests that prescriptions for opioid analgesics and buprenorphine for opioid use disorder decreased among new, but not existing, patients during the COVID-19 pandemic. Read more...

The Impact of Stigma on Treatment Services for People With Substance Use Disorders During the COVID-19 Pandemic

People with SUDs may be experiencing increased stigmatization in different countries during the COVID-19 pandemic. This exacerbated stigma may lead to inadequate care. Health care workers from different countries were asked to share their experiences. Read more...

Putting into practice: Register for our upcoming webinar on stigma and OUD care.